Back to results
US 12,215,172 B2Granted
Bio-responsive adhesive antibody delivery platform for immunotherapy and preparation method thereof
AssigneePostech Academy-Industry Foundation
InventorsKye Il Joo, Hyung Joon Cha, Yeon Su Jeong
Life of this patent
Estimating the term…
Abstract
Disclosed are a bio-responsive adhesive antibody delivery platform for immunotherapy, use thereof, and a preparation method thereof. The bio-responsive adhesive antibody delivery platform for immunotherapy according to the present disclosure may enhance a retention time of the antibody at a target site via adhesiveness of the delivery platform and may selectively release the antibody in response to specific enzymes to efficiently deliver the antibody.
Claims12
A mussel adhesive protein (MAP)-antibody (MAP-Ab) conjugate comprising a MAP and an anti-cancer antibody,
- wherein the MAP is conjugated to the N-terminus of a peptide;
- wherein the anti-cancer antibody is conjugated to the C-terminus of the peptide;
- wherein the peptide is cleavable by a matrix metalloproteinase-2 (MMP2);
- wherein the peptide has the amino acid sequence set forth in SEQ ID NO:
- 12,
- wherein the anti-cancer antibody inhibits a surface protein of a cancer cell;
- wherein when the MAP-Ab conjugate is exposed to an MMP2, the anti-cancer antibody is released therefrom;
- and
- wherein the amino acid sequence of the MAP is selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEO ID NO:
- 4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:
- 10, SEQ ID NO:
- 11, and any combination thereof.
9 more elements
Dependencies are inferred from the claim text.